G907-0330 Screening compound: 1-({1-[(4-chlorophenyl)methyl]-1H-indol-2-yl}methyl)-N-[2-(thiophen-2-yl)ethyl]piperidine-4-carboxamide

G907-0330 Screening compound: 1-({1-[(4-chlorophenyl)methyl]-1H-indol-2-yl}methyl)-N-[2-(thiophen-2-yl)ethyl]piperidine-4-carboxamide
G907-0330 Screening compound: 1-({1-[(4-chlorophenyl)methyl]-1H-indol-2-yl}methyl)-N-[2-(thiophen-2-yl)ethyl]piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G907-0330
1-({1-[(4-chlorophenyl)methyl]-1H-indol-2-yl}methyl)-N-[2-(thiophen-2-yl)ethyl]piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G907-0330

Molecular Formula

C28H30ClN3OS (C28 H30 ClN3 OS)

Compound Name

1-({1-[(4-chlorophenyl)methyl]-1H-indol-2-yl}methyl)-N-[2-(thiophen-2-yl)ethyl]piperidine-4-carboxamide

IUPAC name

1-({1-[(4-chlorophenyl)methyl]-1H-indol-2-yl}methyl)-N-[2-(thiophen-2-yl)ethyl]piperidine-4-carboxamide

SMILES

O=C(C1CCN(Cc2cc(cccc3)c3n2Cc(cc2)ccc2Cl)CC1)NCCc1cccs1

InChI

InChI=1S/C28H30ClN3OS/c29-24-9-7-21(8-10-24)19-32-25(18-23-4-1-2-6-27(23)32)20-31-15-12-22(13-16-31)28(33)30-14-11-26-5-3-17-34-26/h1-10,17-18,22H,11-16,19-20H2,(H,30,33)

InChI Key

AGAPVCAZOPKABB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27167390

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

492.08

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

5.492

Distribution Coefficient, logD

3.394

Water Solubility, LogSw

-6.31

Polar Surface Area

30.179

Acid Dissociation Constant (pKa)

14.07

Base Dissociation Constant (pKb)

9.49

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.10

G907-0330 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

CNS Targets (44014 compounds)

CORONAVIRUS Library (20774 compounds)

MCL1 Targeted Library (12200 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

PLpro Library (6343 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Hemic and lymphatic
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with G907-0330 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G907-0330?
Check Price and Availability of G907-0330, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G907-0330 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G907-0330
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G907-0330
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G907-0330 available by request